Corona Vaccine Boosts Immunotherapy for Cancer Treatment

Here’s a summary of the provided text, focusing on the key findings ⁣and implications:

Key Findings:

* COVID-19 vaccines (specifically mRNA vaccines like Pfizer/BioNTech and Moderna) can substantially improve the effectiveness of immunotherapy in cancer‍ patients. Research⁤ from the ⁣university of Texas, published in Nature, shows this correlation.
* Improved Survival Rates: Patients with advanced lung cancer who received an mRNA COVID-19 vaccine within 100 days⁢ of starting immunotherapy had a 55.7% survival rate after three years, compared to 30.8% in those who hadn’t been vaccinated.
* Mechanism: ⁤ The ⁤vaccine appears to make tumors more sensitive to immunotherapy, overcoming resistance ⁢that some tumors exhibit.
* Past Context: The idea of using infections or immune stimulation to fight cancer isn’t new. ⁣Experiments ‍with injecting dead bacteria to treat cancer‍ date back to the late 19th century, but the underlying mechanisms⁣ are only now being understood ‍with the advent of modern immunotherapy.

Expert Opinion:

* Immunologist Marjolein van Egmond calls the findings a “breakthrough,” stating that‍ while the term is often overused, it’s appropriate in this case. She highlights the long-recognized connection ⁣between the immune system and cancer, and how‍ this research builds on that⁤ understanding.

Implications:

* This research ⁢suggests a potential strategy to ⁣enhance cancer treatment by strategically combining immunotherapy with COVID-19 ⁤vaccination.
* It provides ⁢further insight into the complex interplay between the immune system, vaccines, and cancer.

The text ends ⁣mid-sentence, suggesting there’s more data ‍about the drawbacks ⁣of immunotherapy that⁣ was not included.